Stay updated on Sabatolimab Combo in MDS: Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab Combo in MDS: Clinical Trial page.

Latest updates to the Sabatolimab Combo in MDS: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect the completion of a study and a revision change from v2.14.2 to v2.14.3. Additionally, it clarifies that the study was terminated due to a strategic decision rather than safety concerns.SummaryDifference4%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
Stay in the know with updates to Sabatolimab Combo in MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab Combo in MDS: Clinical Trial page.